Clinical significance of autologous blood transfusions in bone marrow harvest from unrelated donors

Abstract

In the Japan Marrow Donor Program (JMDP), autologous blood is collected from most unrelated bone marrow (BM) donors. We retrospectively evaluated 5772 donors who underwent BM harvest between 2010 and 2015 through the JMDP. Autologous blood was collected in 96.8% of the donors; the wastage rate was 0.6%. Allogeneic blood transfusion was not required. The mean hemoglobin (Hb) levels were 12.1 g/dL after the BM harvest (mean 891 mL) together with autologous blood transfusion (mean 596 mL). Propensity-score matching was used to adjust the backgrounds. Among donors with harvested BM of 100–400 mL, autologous blood transfusion had no impact on Hb levels or complications after BM harvest. Among donors with harvested BM of > 400 mL, more autologous blood transfusion followed by a bleeding volume of ≤ 100 mL did not confer clinical benefit to donors compared with less autologous blood transfusion followed by a bleeding volume of > 300 mL. The findings of the present study suggest that autologous blood transfusion to BM donors is excessive in terms of Hb changes and post-harvest outcomes.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. 1.

    Vassallo R, Goldman M, Germain M, Lozano M. Preoperative autologous blood donation: waning indications in an era of improved blood safety. Transfus Med Rev. 2015;29:268–75.

    Article  Google Scholar 

  2. 2.

    The Japan Marrow Donor Program, About JMDP. https://www.jmdp.or.jp/english.html.

  3. 3.

    Parkkali T, Juvonen E, Volin L, Partanen J, Ruutu T. Collection of autologous blood for bone marrow donation: how useful is it? Bone Marrow Transplant. 2005;35:1035–9.

    CAS  Article  Google Scholar 

  4. 4.

    Mijovic A, Britten C, Regan F, Harrison J. Preoperative autologous blood donation for bone marrow harvests: are we wasting donors' time and blood? Transfus Med. 2006;16:57–62.

    CAS  Article  Google Scholar 

  5. 5.

    Gouezec H, Ferre N, Herve F, Lapart C, Leberre C, Bernard M, et al. Suitability of autologous blood donation before bone marrow donation. Transfus Clin Biol. 2015;22:71–5.

    CAS  Article  Google Scholar 

  6. 6.

    Manuel SP, Spitzer TR, Ishizawa Y. Preoperative autologous blood donation in healthy bone marrow donors contributes to pre-procedure anemia. Bone Marrow Transplant. 2017;52:1191–3.

    CAS  Article  Google Scholar 

  7. 7.

    Spitzer TR, Sugrue MW, Gonzalez C, O'Donnell P, Confer D, Fuchs E, et al. Transfusion practices for bone marrow harvests: a survey analysis from the AABB Bone Marrow Quality Improvement Initiative Working Group. Bone Marrow Transplant. 2017;52:1199–200.

    CAS  Article  Google Scholar 

  8. 8.

    Arora K, Kelley J, Martinez F, Tholpady A. Preoperative autologous blood collection before bone marrow harvests in haploidentical related donors: is it justified? Transfusion. 2018;58:1618–25.

    Article  Google Scholar 

  9. 9.

    Gilli IO, Vigorito AC, Benites BD. Revisiting old practices: More restricted indication of preoperative autologous blood donation in healthy bone marrow donors according to baseline hemoglobin levels. Transfus Apher Sci. 2019;58:323–5.

    Article  Google Scholar 

  10. 10.

    NMDP/Be The Match 24th Edition Standards and Glossary (effective January 1, 2018). https://bethematch.org/about-us/global-transplant-network/standards/.

  11. 11.

    World Marrow Donor Association International Standards for Unrelated Haematopoietic Stem Cell Donor Registries (effective January 1, 2017). https://www.wmda.info/professionals/quality-and-accreditation/wmda-standards/.

  12. 12.

    Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

    CAS  Article  Google Scholar 

  13. 13.

    Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2016;10:Cd002042.

    PubMed  Google Scholar 

  14. 14.

    Girelli D, Ugolini S, Busti F, Marchi G, Castagna A. Modern iron replacement therapy: clinical and pathophysiological insights. Int J Hematol. 2018;107:16–30.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The authors thank all physicians at the collection centers who contributed valuable data on BM harvest to the JMDP. The authors also thank all the members of the data management committees of JMDP for their assistance.

Author information

Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Data analysis were performed by S.F. The first draft of the manuscript was written by SF and KM and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Shin-ichiro Fujiwara.

Ethics declarations

Conflict of interest

The authors report no potential competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fujiwara, Si., Ikeda, K., Kino, S. et al. Clinical significance of autologous blood transfusions in bone marrow harvest from unrelated donors. Int J Hematol 111, 833–839 (2020). https://doi.org/10.1007/s12185-020-02851-8

Download citation

Keywords

  • Autologous blood transfusion
  • Bone marrow harvest
  • Unrelated donor